Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics Raises $6M in Private Financing Round

NEW YORK, Sept. 15 (GenomeWeb News) - Rosetta Genomics of Rehovot, Israel, has raised $6 million in a private investment round, GenomeWeb News has learned.

 

The financing was led by Yossi Ben-Yosef's Kadima High Tech, which was joined by Coronis Partners, GlenRock Israel, and others.

 

Earlier this week, Rosetta said it gave Ambion access to Rosetta's proprietary microRNA sequences.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.